News & Updates

September 2014

Hydrocodone Combination Products (HCPs) will be moving from a Schedule III controlled substance to the more-restrictive Schedule II, effective Oct. 6, 2014. The U.S. Drug Enforcement Administration’s (DEA) rescheduling of HCPs as Schedule II will increase restrictions on prescribing and dispensing practices for HCPs.

In preparation for the DEA rescheduling of HCPs, the Texas Department of Public Safety (DPS) has increased staffing and resources to respond to medical practitioners needing assistance so they can better serve Texans who require prescriptions for HCPs.

Medical and mid-level practitioners will need to have correct schedule designations on their registrations with DPS. Practitioners need to use NAR-116 and Mid-Level Practitioners need to use NAR-117 to submit updates.

For more information, please see Hydrocodone: Schedule II Controlled Substance, DPS’ Press Release and DEA Announcement.

August 2014

According to Senate Bill 406, practitioners may now delegate the prescribing / ordering of Schedule II Controlled Substances in a hospital facility-based practice consistent with hospital policy, if the patient has been admitted to the hospital for 24 hours or longer, or if the patient is receiving services in the emergency department. Practitioners may also delegate the prescribing authority of Schedule II Controlled Substances as a part of a plan of care for a terminal patient receiving hospice treatment from a qualified hospice provider. For additional information, please visit Texas Medical Board Prescriptive Delegation.

Placement of Tramadol into Schedule IV (final rule)
With the issuance of this final rule, the deputy administrator of the Drug Enforcement Administration places the substance 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol (tramadol), including its salts, isomers, and salts of isomers, into schedule IV of the Controlled Substances Act. This scheduling action is pursuant to the Controlled Substances Act which requires that such actions be made on the record after opportunity for a hearing through formal rulemaking. This action imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule IV controlled substances on persons who handle (manufacture, distribute, dispense, import, export, engage in research, conduct instructional activities with, or possess) or propose to handle tramadol.

October 2013

E-Prescribe now available for Schedule II Controlled Substances
Effective Oct. 30, 2013, Schedule II Controlled Substances can now be filed electronically. DPS has designated the placeholder value of 010000000000 (01 plus 10 zeroes) as the E-Prescription Control Number.

September 2011

Requirement to provide DEA Registration Number within 45 days –Senate bills 594 and 1273 require a registrant to provide their DEA Registration Number to DPS within 45 days following the issuance of their DPS Registration Number.

Guidelines for e-prescribing Schedule II Controlled Substances –Senate Bill 594 states an Official Prescription Form is not required when a practitioner e-prescribes a Schedule II Controlled Substance in accordance with Federal law.

Controlled Substance prescription information to DPS within 7 days –Senate bills 594 and 1273 state a pharmacy must transmit to DPS’ Texas Prescription Program controlled substance prescription information within seven days after the prescription is completely filled.